Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk factors for venous thromboembolism during pregnancy.
Jensen TB, Gerds TA, Grøn R, Bretler DM, Schmiegelow MD, Andersson C, Azimi A, Gislason G, Torp-Pedersen C, Olesen JB. Jensen TB, et al. Among authors: gron r. Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1283-91. doi: 10.1002/pds.3536. Epub 2013 Oct 16. Pharmacoepidemiol Drug Saf. 2013. PMID: 24130063
Authors' reply.
Kessing LV, Grøn R, Andersen PK. Kessing LV, et al. Among authors: gron r. Br J Psychiatry. 2013 Jun;202:465. Br J Psychiatry. 2013. PMID: 23882706 No abstract available.
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).
Brown-Frandsen K, Emerson SS, McGuire DK, Pieber TR, Poulter NR, Pratley RE, Zinman B, Ranthe MF, Grøn R, Lange M, Moses AC, Örsy P, Buse JB; DEVOTE Study Group. Brown-Frandsen K, et al. Among authors: gron r. Diabetes Obes Metab. 2019 Jun;21(6):1437-1444. doi: 10.1111/dom.13677. Epub 2019 Apr 1. Diabetes Obes Metab. 2019. PMID: 30793465 Free PMC article. Clinical Trial.
IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy.
Miller E, Doshi A, Grøn R, Jódar E, Őrsy P, Ranthe MF, Sugimoto D, Tentolouris N, Viljoen A, Billings LK. Miller E, et al. Among authors: gron r. Diabetes Obes Metab. 2019 Dec;21(12):2643-2650. doi: 10.1111/dom.13851. Epub 2019 Aug 28. Diabetes Obes Metab. 2019. PMID: 31385425 Free PMC article. Clinical Trial.
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.
Aroda VR, González-Galvez G, Grøn R, Halladin N, Haluzík M, Jermendy G, Kok A, Őrsy P, Sabbah M, Sesti G, Silver R. Aroda VR, et al. Among authors: gron r. Lancet Diabetes Endocrinol. 2019 Aug;7(8):596-605. doi: 10.1016/S2213-8587(19)30184-6. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189519 Clinical Trial.
14 results